Protalix BioTherapeutics (PLX) Q2 2023 Earnings

7AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.15
-0.03
0.09
0.21

Details

Expected EPS
-0.04
Actual EPS
0.21
Surprise EPS
0.25
Surprise Percent
+625%

Description

Protalix BioTherapeutics (PLX) has reported earnings of 0.21 per share for Q2 2023.

0 Comments

Share your thoughts